- Home
- NIXX vs QNCX Comparison
NIXX vs QNCX Comparison
Compare NIXX & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NIXX
- QNCX
- Stock Information
- Founded
- NIXX 2010
- QNCX 2012
- Country
- NIXX United States
- QNCX United States
- Employees
- NIXX N/A
- QNCX N/A
- Industry
- NIXX
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NIXX
- QNCX Health Care
- Exchange
- NIXX NYSE
- QNCX Nasdaq
- Market Cap
- NIXX 66.8M
- QNCX 62.0M
- IPO Year
- NIXX N/A
- QNCX 2019
- Fundamental
- Price
- NIXX $1.96
- QNCX $1.40
- Analyst Decision
- NIXX
- QNCX Strong Buy
- Analyst Count
- NIXX 0
- QNCX 4
- Target Price
- NIXX N/A
- QNCX $9.50
- AVG Volume (30 Days)
- NIXX 213.0K
- QNCX 110.3K
- Earning Date
- NIXX 04-15-2025
- QNCX 03-31-2025
- Dividend Yield
- NIXX N/A
- QNCX N/A
- EPS Growth
- NIXX N/A
- QNCX N/A
- EPS
- NIXX N/A
- QNCX N/A
- Revenue
- NIXX $668,693.00
- QNCX N/A
- Revenue This Year
- NIXX $209.13
- QNCX N/A
- Revenue Next Year
- NIXX N/A
- QNCX N/A
- P/E Ratio
- NIXX N/A
- QNCX N/A
- Revenue Growth
- NIXX N/A
- QNCX N/A
- 52 Week Low
- NIXX $1.20
- QNCX $0.51
- 52 Week High
- NIXX $8.50
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- NIXX N/A
- QNCX 37.98
- Support Level
- NIXX N/A
- QNCX $1.38
- Resistance Level
- NIXX N/A
- QNCX $1.54
- Average True Range (ATR)
- NIXX 0.00
- QNCX 0.11
- MACD
- NIXX 0.00
- QNCX -0.00
- Stochastic Oscillator
- NIXX 0.00
- QNCX 9.37
About NIXX NIXXY INC
Nixxy Inc formerly Recruiter.Com Group Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize a web platform, complete with AI-driven job matching, to recruit talent faster. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing innovative precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics.